Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEntain Regulatory News (ENT)

Share Price Information for Entain (ENT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 785.40
Bid: 788.60
Ask: 789.00
Change: 2.20 (0.28%)
Spread: 0.40 (0.051%)
Open: 789.00
High: 805.20
Low: 785.40
Prev. Close: 783.20
ENT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offer Talks Terminated

26 Oct 2021 12:46

RNS Number : 3123Q
DraftKings Inc.
26 October 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS ANNOUNCEMENT IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

FOR IMMEDIATE RELEASE

26 October 2021

 

DraftKings Inc. ("DraftKings")

 

Statement regarding Entain plc ("Entain")

 

DraftKings (NASDAQ: DKNG) confirms that, following further analysis and discussions with the Entain board of directors, it will not make a firm offer for Entain.

Commenting on this, Jason Robins DraftKings CEO, Co-Founder and Chairman of the Board said:

"After several discussions with Entain leadership, DraftKings has decided that it will not make a firm offer for Entain at this time. Based on our vertically-integrated technology stack, best-in-class product and technology capabilities and leading brand, we are highly confident in our ability to maintain a leadership position and achieve our long-term growth plans in the rapidly growing North America market."

As a result of this announcement, DraftKings is bound by the restrictions under Rule 2.8 of the Code for six months following the date of this announcement.

For the purpose of Rule 2.8 of the Code, DraftKings reserves the right to set aside the above statement and the restrictions in Rule 2.8 of the Code in the following circumstances:

(i) with the agreement of the board of directors of Entain;

(ii) following the announcement of a firm intention to make an offer for Entain by or on behalf of a third party;

(iii) following the announcement by Entain of a "whitewash" proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); or

(iv) where the Takeover Panel has determined that there has been a material change of circumstances.

 

Enquiries

 

Press:

Joe DeCristofaro, Investor Relations

Media@draftkings.com

+1 617 986 6744

 

 

The Raine Group, financial adviser to DraftKings

 

+44 20 3695 8600

 

John Salter

Colin Neville

Jason Schretter

Brett Varsov

Garrett Gomes

 

 

 

Credit Suisse, financial adviser to DraftKings

 

+44 20 7888 8888

 

Michael Kamras

Joe Hannon

Ben Deary

Matt Hall (Corporate Broking)

 

 

 

 

 

Important Notices

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of any vote in any jurisdiction whether pursuant to this announcement or otherwise, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

The release, publication or distribution of this announcement in whole or in part, directly or indirectly, in, into or from certain jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.

Financial Advisers

Raine Advisors Limited ("Raine"), which is an Appointed Representative of Sapia Partners LLP, an entity which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (FRN: 550103), is acting as financial adviser exclusively for DraftKings and no one else in connection with the matters set out in this announcement and will not be responsible to any person other than DraftKings for providing the protections afforded to clients of Raine, nor for providing advice in relation to the content of this announcement or any matter referred to herein. Neither Raine nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Raine in connection with this announcement, any statement contained herein or otherwise.

 

Credit Suisse International ("Credit Suisse"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the UK, is acting as financial adviser exclusively for DraftKings and no one else in connection with the matters set out in this announcement and will not be responsible to any person other than DraftKings for providing the protections afforded to clients of Credit Suisse, nor for providing advice in relation to the content of this announcement or any matter referred to herein. Neither Credit Suisse nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Credit Suisse in connection with this announcement, any statement contained herein or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OTTDZMZGMVFGMZM
Date   Source Headline
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20243:03 pmRNSDirector/PDMR Shareholding
29th Apr 20247:00 amRNSSuccessful repricing of Term Loans & £600m add-on
26th Apr 20249:56 amRNSBoard Committee Changes
24th Apr 202412:09 pmRNSResult of AGM
17th Apr 20247:00 amRNSQ1 Trading Update
16th Apr 20249:17 amRNSTR1: Notification of Major Holdings
4th Apr 20247:00 amRNSChairman Succession
2nd Apr 20247:00 amRNSBlock Listing Six Monthly Return
2nd Apr 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:42 amRNSAnnual Report, AGM and Gender Pay Gap Report
12th Mar 202411:41 amRNSDirector/PDMR Shareholding
12th Mar 202410:00 amRNSBoard Appointment
11th Mar 20241:54 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFY23 results in line with expectations
1st Mar 20247:00 amRNSTotal Voting Rights
19th Feb 20247:00 amRNSTR1: Notification of Major Holdings
8th Feb 20242:00 pmRNSBETMGM FY23 UPDATE
6th Feb 20242:00 pmRNSNotice of BetMGM FY 2023 update
2nd Feb 20244:11 pmRNSNew Board Committee
1st Feb 20247:00 amRNSTotal Voting Rights
3rd Jan 20249:27 amRNSTR1: Notification of Major Holdings
3rd Jan 20247:00 amRNSBoard Appointment
2nd Jan 20248:29 amRNSTotal Voting Rights
15th Dec 20234:00 pmRNSBoard Committee Changes
13th Dec 20237:00 amRNSDirectorate Change
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSBetMGM at Morgan Stanley Consumer Conference
5th Dec 20232:06 pmRNSFinal Approval of Deferred Prosecution Agreement
4th Dec 20232:00 pmRNSBetMGM Business Update
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 202310:42 amRNSStatement regarding KSA decisions
27th Nov 20232:00 pmRNSBetMGM Business Update Event Details
24th Nov 20232:01 pmRNSUpdate on Deferred Prosecution Agreement
15th Nov 202311:00 amRNSDirector/PDMR Shareholding
8th Nov 20232:00 pmRNSTR1: Notification of Major Holdings
8th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20233:39 pmRNSTR1: Notification of Major Holdings
6th Nov 20239:12 amRNSTR1: Notification of Major Holdings
2nd Nov 20237:00 amRNSQ3 Trading Statement & Business Update
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSBoard Appointment
4th Oct 20232:00 pmRNSNotice of BETMGM Business Update Event
4th Oct 202311:30 amRNSTR1: Notification of Major Holdings
2nd Oct 202312:35 pmRNSBlock Listing Six Monthly Return
2nd Oct 20239:11 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSCompletion of acquisition of Angstrom Sports
25th Sep 20237:00 amRNSUpdate on current trading and operational strategy
5th Sep 20232:00 pmRNSBetMGM participate in Bank of America Conference

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.